SCHEMBL3428061

SCHEMBL3428061

COc1cccc(-n2nc(OC(=O)O)cc2-c2cccc(F)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 7/20 0.48
SLC16A1 P53985 7/20 0.48
MCTS1 Q9ULC4 3/20 0.48
RPA1 P27694 2/20 0.44
NSD2 O96028 1/20 0.44
NSD1 Q96L73 1/20 0.44
NSD3 Q9BZ95 1/20 0.44
LPAR5 Q9H1C0 1/20 0.44
HPSE Q9Y251 1/20 0.44
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.42
SLC5A1 P13866 3/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3430532 0.87 SLC16A3 (0.62) SLC16A3SLC16A1MCTS1RPA1NSD2
SCHEMBL3429299 0.86 ALDH1A1 (0.46) SLC16A3SLC16A1MCTS1MAPTLMNA
SCHEMBL1110894 0.86 SLC16A3 (0.48) SLC16A3SLC16A1MCTS1NSD2NSD1
SCHEMBL3430105 0.85 KMT2A (0.54) RPA1MAPTLMNASLC5A1
SCHEMBL1764984 0.84 RPA1 (0.63) SLC16A3SLC16A1MCTS1RPA1NSD2
SCHEMBL3428023 0.83 SLC16A3 (0.54) SLC16A3SLC16A1MCTS1RPA1NSD2
SCHEMBL3428213 0.82 MEN1 (0.51) SLC16A3SLC16A1MCTS1RPA1SMN1; SMN2
SCHEMBL3431022 0.81 RPA1 (0.47) RPA1
SCHEMBL3428855 0.78 PPP1CA (0.50) SLC16A3SLC16A1MCTS1SLC5A1
SCHEMBL1765356 0.78 FAAH (0.56) RPA1CA9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254885-A1 (PYRAZOLYL CARBONYL)IMIDAZOLIDINONE DERIVATIVES FOR THE TREATMENT OF RETROVIRAL DISEASES AiCuris GmbH & Co. KG (DE) 2010-12-01 EP disclosed
WO-2009115213-A1 (PYRAZOLYL CARBONYL)IMIDAZOLIDINONE DERIVATIVES FOR THE TREATMENT OF RETROVIRAL DISEASES AICURIS GMBH & CO. KG (DE) 2009-09-24 WO disclosed